Major Bayer shareholder Harris has expressed support for the CEO's emphasis on internal restructuring within the company. This backing comes as Bayer continues to navigate challenges and implement strategic changes to enhance its operations.
The CEO's focus on internal restructuring is aimed at improving efficiency, streamlining processes, and driving innovation across Bayer's various business units. By prioritizing these efforts, Bayer aims to position itself for long-term success and sustainable growth in the competitive market landscape.